Effectiveness, tolerability and patient satisfaction of paediatric live-attenuated influenza immunization (LAIV) in routine-care in Germany: A case-control-study

Trials in Vaccinology

Volumn 2, Issue 1, 2013, Pages 49-52

  Rose, M A ^a   Stoermann, J ^b   Bittner Brewe, J ^b   Rosewich, M ^a   Eickmeier, O ^a   Schulze, J ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Paediatric Office   (Germany)

Author keywords

Asthma; Children; Live attenuated influenza vaccine; Patients' satisfaction; Routine care; Tolerability

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ARTICLE; BRONCHITIS; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GERMANY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MODERATE PERSISTENT ASTHMA; NOSE OBSTRUCTION; PATIENT SATISFACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEASONAL INFLUENZA; URTICARIA; WHEEZING;

EID: 84889081618     PISSN: None     EISSN: 18794378     Source Type: Journal    
DOI: 10.1016/j.trivac.2013.09.003     Document Type: Article

References (16)

1. S. Buda, B. Schweiger, U. Buchholz, K. Köpke, K. Prahm, Haas W and the influenza working group. RKI Influenza-monthly report 11.05.-07.06.2013; 2. Available from: < http://influenza.rki.de/Wochenberichte/2012-2013/2013-23. pdf >.
2. C. Folli, D. Descalzi, F. Scordamaglia, A.M. Iccio, C. Gamalero, and G.W. Canonica New insights into air way remodelling in asthma and its possible modulation Curr. Opin. Allergy Clin. Immunol. 8 2008 367 375
3. J.J. McKenna, A.M. Bramley, J. Skarbinski, A.M. Fry, L. Finelli, and S. Jain 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009 BMC Infect. Dis. 31 13 2013 57
4. M.A. Rose, R. Schubert, S. Kujumdshiev, R. Kitz, and S. Zielen Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma Int. J. Clin. Pract. 60 11 2006 1425 1431 (Pubitemid 44560342)
5. R.B. Belshe, C.S. Ambrose, and T. Yi Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age Vaccine 12 26 2008 D10 D16 (Suppl. 4)
6. W.P. Glezen, M.J. Gaglani, C.A. Kozinetz, and P.A. Piedra Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza strains J. Infect. Dis. 202 11 2010 1626 1633
7. J. Rhorer, C.S. Ambrose, S. Dickinson, H. Hamilton, N.A. Oleka, F.J. Malinoski, and J. Wittes Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials Vaccine 27 7 2009 1101 1110
8. T. Jefferson et al., Cochrane Database of Systematic Reviews 2008; Issue 2. Art no.:CD004879.
9. M.A. Rose, S. Zielen, and U. Baumann Mucosal immunity and nasal influenza vaccination Expert Rev. Vaccines 11 5 2012 595 607
10. B. Wedi, U. Rapp, D. Wieczorek, and A. Kapp Urticaria and infections Allergy Asthma Clin. Immunol. 5 2009 10
11. R. Bergen, S. Black, H. Shinefield, E. Lewia, P. Ray, and J. Hansen Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents Pediatr. Infect. Dis. J. 23 2004 138 144 (Pubitemid 38222786)
12. P. Tennis, S.L. Toback, E. Andrews, L.J. McQuay, and C.S. Ambrose A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years Vaccine 29 31 2011 4947 4952
13. M.J. Gaglani, P.A. Piedra, M. Riggs, G. Herschler, C. Fewlass, and W.P. Glezen Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial Pediatr. Infect. Dis. J. 27 5 2008 444 452
14. S. Ashkenazi, A. Vertuyen, J. Aristegui, S. Esposito, D.D. McKeith, T. Klemola et al., Superior relative efficacy of LAIV compred with inactivated influenzas vaccine in young children with recurrent respiratory tract infections, Pediatr. Infect. Dis. J. (2006) 25-870-9.
15. P. Tennis, S.L. Toback, E.B. Andrews, L.J. McQuay, and C.S. Ambrose A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season Vaccine 30 42 2012 6099 6102
16. R. Baxter, S.L. Toback, F. Sifakis, J. Hansen, J. Bartlett, and L. Aukes A postmarketing evacuation of the safety of Ann Arbor strain LAIV in children 5-17 years of age Vaccine 30 2012 2989 2998